The retinal biologics market experienced significant growth in 2021, with total revenue reaching an impressive USD 19.96 billion. This upward trajectory is expected to accelerate further, as the global market is projected to more than double, reaching USD 41.92 billion by 2028. The market’s robust compound annual growth rate (CAGR) of 11.1% from 2022 to 2028 highlights the increasing demand for innovative biologics to address retinal disorders.
Key Drivers of Market Expansion
Several factors are fueling this exceptional growth. The rising prevalence of retinal diseases such as age-related macular degeneration (AMD), diabetic retinopathy, and retinal vein occlusion has underscored the need for advanced and effective biologic treatments. Innovations in delivery mechanisms, combined with a surge in research and development investments, are driving the adoption of biologics as a preferred treatment modality.
Emerging Trends and Opportunities
The market is also benefiting from technological advancements in retinal care, including sustained-release formulations and gene therapies. These breakthroughs aim to enhance patient outcomes while reducing treatment burden. Furthermore, increased access to healthcare in emerging economies and government initiatives to combat vision-related disorders contribute to the global expansion of the retinal biologics market.
Get Full Report Now – https://www.futuremarketinsights.com/reports/retinal-biologics-market
Future Outlook: Sustained Growth Ahead
With a focus on addressing unmet clinical needs and improving patient quality of life, the retinal biologics market is poised for sustained growth. Stakeholders in the pharmaceutical and biotechnology sectors are well-positioned to capitalize on this momentum by advancing innovative therapies and expanding their reach across global markets.
Key Takeaways:
- The retinal biologics market generated US$ 19.96 billion in revenue in 2021 and is expected to grow to US$ 41.92 billion by 2028.
- The market is projected to grow at a CAGR of 11.1% from 2022 to 2028.
- Rising prevalence of retinal diseases and innovations in biologics are key growth drivers.
- Emerging technologies, expanded access to healthcare, and R&D investments are shaping the market’s future.
Growth Drivers
- Rising Prevalence of Retinal Diseases: The increasing incidence of retinal conditions, such as age-related macular degeneration and diabetic retinopathy, is driving demand for effective treatments. According to the World Health Organization, approximately 2.2 billion people globally suffer from vision impairment, highlighting the need for advanced therapeutic options.
- Innovations in Treatment: Significant advancements in retinal biologics, including the development of new drugs and improved delivery systems, are enhancing treatment efficacy and patient outcomes. Innovations such as intravitreal injections and sustained-release formulations are particularly noteworthy.
- Increased Research and Development: There is a growing focus on R&D activities aimed at discovering novel biologics for retinal diseases, which is expected to fuel market expansion. Companies are investing heavily in developing new therapies that target specific pathways involved in retinal diseases.
- Regulatory Support: Favorable regulatory environments and expedited approval processes for innovative biologics are facilitating faster market entry for new therapies.
- Aging Population: The global aging demographic is contributing to a higher prevalence of age-related ocular diseases, thereby increasing the demand for retinal biologics.
Key Companies Profiled
Spark Therapeutics, Inc.; F. Hoffmann-La Roche Ltd.; Regeneron Pharmaceuticals, Inc.; AbbVie Inc.; Amgen Inc.; Novartis Pharma AG; MeiraGTx Limited; Oxurion NV; Santen Pharmaceutical Co., Ltd.; Bayer AG; Bausch Health Companies Inc.; Merck & Co., Inc.
Key Segments of Retinal Biologics Industry Survey
Retinal Biologics Market by Drug Class:
- VEGF-A Antagonists
- TNF-α Inhibitors
Retinal Biologics Market by Indication:
- Macular Degeneration
- Diabetic Macular Edema
- Diabetic Retinopathy
- Uveitis
- Others
Retinal Biologics Market by Distribution Channel:
- Institutional Sales
- Retail Pharmacies
- Mail Order Pharmacies
- Retail Sales
Retinal Biologics Market by Region:
- North America Retinal Biologics Market
- Latin America Retinal Biologics Market
- Europe Retinal Biologics Market
- East Asia Retinal Biologics Market
- South Asia & Pacific Retinal Biologics Market
- Middle East & Africa (MEA) Retinal Biologics Market
Author By:
Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.
Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in areas such as Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.
Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube
